The Impact of Continuous Glucose Monitoring Use on Sleep in Parents of Children With Type 1 Diabetes Mellitus
NCT ID: NCT01425255
Last Updated: 2016-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2011-08-31
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real-Time Continuous Glucose Monitoring in Pre-School Children With Type-1 Diabetes Mellitus
NCT01016457
Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus Patients
NCT01525784
Effect of Sleep Apnea Treatment on Type 1 Diabetes
NCT02316665
Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes
NCT01586065
Sleep and Type 1 Diabetes
NCT02494375
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parents of children with Type 1 diabetes
before and several weeks after initiating using RT-CGM of their children.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel Aviv Medical Center
OTHER
Sheba Medical Center
OTHER_GOV
Wolfson Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
zohar landau
Head of Pediatric Endocrinology Service
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zohar Landau, MD
Role: PRINCIPAL_INVESTIGATOR
Wolfson Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
E. Wolfson Medical Center
Holon, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0077-11-WOMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.